Cell Therapy Catapult Ltd - Medical Equipment - Deals and Alliances Profile

Summary

Cell Therapy Catapult Ltd (Catapult) is a provider of cell and gene therapy life cycle solutions. The company offers services such as industrialization, manufacturing, regulatory, health economics and market access, non-clinical safety and clinical operations. Its health economics and market access provide pricing and reimbursement and commercial management for gene therapies and other types of therapies. Catapult provides technology platform and clinical trials. The company also offers reimbursement and adoption of therapies. It partners healthcare sector and clinical researchers. Catapult is headquartered in London, the UK.

Cell Therapy Catapult Ltd - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Cell Therapy Catapult Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cell Therapy Catapult Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cell Therapy Catapult Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cell Therapy Catapult Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cell Therapy Catapult Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cell Therapy Catapult Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Asymptote Enters into Licensing Agreement with Cell and Gene Therapy Catapult 10
Cell Therapy Catapult Enters into Agreement with Asymptote 11
Cell Therapy Catapult, Azellon, University of Liverpool and NHS Blood and Transplant Enter into Agreement 12
ReNeuron Enters Into Co-Development Agreement With Cell Therapy Catapult 13
Cell Therapy Catapult Ltd - Key Competitors 14
Cell Therapy Catapult Ltd - Key Employees 15
Cell Therapy Catapult Ltd - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 16
Recent Developments 17
Strategy And Business Planning 17
Apr 23, 2018: Cell and Gene Therapy Catapult Opens Manufacturing Centre to Accelerate Growth of the Industry in the UK 17
Corporate Communications 19
Oct 18, 2018: CGT Catapult names Three New Board Members 19
Jun 06, 2018: Cell and Gene Therapy Catapult Appoints Dr Jonathan Appleby As Chief Scientific Officer 21
Other Significant Developments 22
Feb 28, 2018: CGT Catapult holds inaugural Seminar Series 22
Nov 13, 2017: Cell and Gene Therapy Catapult research highlights the UKs growing global leadership in innovative cell and gene therapy industry 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List Of Tables


Cell Therapy Catapult Ltd, Medical Equipment, Key Facts, 2017 2
Cell Therapy Catapult Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cell Therapy Catapult Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cell Therapy Catapult Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cell Therapy Catapult Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cell Therapy Catapult Ltd, Deals By Market, 2012 to YTD 2018 8
Cell Therapy Catapult Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Asymptote Enters into Licensing Agreement with Cell and Gene Therapy Catapult 10
Cell Therapy Catapult Enters into Agreement with Asymptote 11
Cell Therapy Catapult, Azellon, University of Liverpool and NHS Blood and Transplant Enter into Agreement 12
ReNeuron Enters Into Co-Development Agreement With Cell Therapy Catapult 13
Cell Therapy Catapult Ltd, Key Competitors 14
Cell Therapy Catapult Ltd, Key Employees 15
Cell Therapy Catapult Ltd, Subsidiaries 16
Cell Therapy Catapult Ltd, Joint Venture 16

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Asia Pacific Canine Stem Cell Therapy Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Canine Stem Cell Therapy market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million

USD 3000 View Report

Europe Canine Stem Cell Therapy Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Europe Canine Stem Cell Therapy market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD

USD 3000 View Report

Asia Pacific Canine Stem Cell Therapy Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Canine Stem Cell Therapy market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million

USD 3000 View Report

Europe Canine Stem Cell Therapy Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Europe Canine Stem Cell Therapy market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available